Drug intelligence / Profile preview

CTX-inho phage

Development stage
Preclinical
Modality
Gene Therapies, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

CTX-inho phage is an research-stage engineered M13 bacteriophage-based nanocarrier platform developed for targeted imaging and therapeutic delivery to glioblastoma (GBM) brain tumors. The platform is produced by fusing a chlorotoxin (CTX) motif to the p3 capsid protein of the M13 phage, which enables the particles to cross the blood-brain barrier and home specifically to glioblastoma cells. It incorporates the 'inho' circular single-stranded DNA (cssDNA) gene packaging system, which allows for the production of miniature phage particles (approximately 50 nm in length) and the delivery of transcriptionally active cssDNA transgene cassettes. In preclinical mouse models of intracranial GBM22 glioblastoma, systemically administered CTX-inho phage conjugated with indocyanine green has demonstrated the ability to accumulate in brain tumors and enable shortwave infrared (SWIR) imaging.

02

Targets

DNA (Mammalian Deoxyribonucleic Acid)ClC (CLC chloride channel family)MMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on CTX-inho phage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTX-inho phage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call